Probing the molecular program of apoptosis by cancer chemopreventive agents
Authors:
- Zsuzsa SzondyZSZsuzsa Szondy
- Ivan UrayIUIvan Uray
- 1 January 1995
- journal article
- review article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 59 (S22) , 151-161
Abstract
This paper provides a rational molecular basis for studies intended to clarify the interactions between cancer chemopreventive agents and apoptosis, one of the natural forms of cell death that overlaps molecular mechanisms with other forms such as programmed cell death and specialized forms of physiological cell death. Molecular details of the process show the existence of distinct molecular pathways leading to the activation of critical effector elements (apoptosis gene products) functioning under the control of network of negative regulatory elements. Dysregulation of either apoptosis or anti‐apoptosis genes has a significant role in multistage carcinogenesis. Inhibition of apoptosis is one of the underlying mechanisms of the action of tumor promoters. The network of apoptosis and anti‐apoptosis gene products provides multiple targets for compounds with cancer chemopreventive potential. Many data in the literature show initiating, potentiating or inhibitory effects of such compounds on apoptosis. However, the molecular mechanism of these effects is largely unknown. We initiated a series of studies using mouse thymocytes which undergo apoptosis through distinct molecular mechanisms after T‐cell receptor activation (TCR pathway), following the addition of glucocorticoids (DEX pathway) or DNA damaging agents (p53 pathway). All trans‐and 9‐cis‐retinoic acid induced apoptosis, elicited through the DEX pathway, inhibited the TCR pathway, and did not affect p53‐ initiated apoptosis. N‐acetylcysteine can inhibit all forms. Sodium salicylate enhanced spontaneous cell death, decreased p53‐dependent apoptosis, and did not affect the DEX and TCR pathways. These preliminary results, which show differential effects of the studied compounds on distinct molecular pathways of apoptosis, warrant further investigations in the effort to utilize the molecular elements of apoptosis in proper cancer chemoprevention, and find biochemical targets for apoptosis‐related surrogate endpoint biomarker assays of chemoprevention.Keywords
This publication has 38 references indexed in Scilit:
- Inhibition of NF-κB by Sodium Salicylate and AspirinScience, 1994
- The selenium metabolite selenodiglutathione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium?Carcinogenesis, 1994
- Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell lineCarcinogenesis, 1994
- Dicing with death: dissecting the components of the apoptosis machineryTrends in Biochemical Sciences, 1994
- Apoptosis in Toremifene-Induced Growth Inhibition of Human Breast Cancer Cells In Vivo and In VitroJNCI: Journal of the National Cancer Institute, 1993
- Biochemical events in naturally occurring forms of cell deathFEBS Letters, 1993
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- ApoptosisImmunology Today, 1993
- Homodimer formation of retinoid X receptor induced by 9-cis retinoic acidNature, 1992
- Mechanisms and Functions of Cell DeathAnnual Review of Cell Biology, 1991